Mirum Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	296.68	222.5	286.33	28	31.34
Short-Term Investments	86.64	57.81	-	123.72	125.2
Cash & Short-Term Investments	383.33	280.32	286.33	151.72	156.54
Cash Growth	36.75%	-2.10%	88.72%	-3.08%	-32.47%
Accounts Receivable	123.33	78.29	67.97	23.99	3.27
Inventory	24.89	22.4	22.31	5.57	1.51
Other Current Assets	18.14	11.78	10.94	8.95	5.27
Total Current Assets	549.68	392.79	387.54	190.23	166.59
Net Property, Plant & Equipment	10.6	9.81	1.99	60.39	2.55
Other Intangible Assets	260.92	249.82	252.93	1.38	18.74
Long-Term Investments	8.11	12.53	-	-	4.98
Other Long-Term Assets	13.5	5.81	4.17	0.91	101.79
Total Assets	842.81	670.75	646.62	352.91	294.65
Accounts Payable	9.61	14.62	7.42	8.69	9.17
Accrued Expenses	196.19	111.93	78.54	54.02	30.72
Current Portion of Leases	-	-	1.1	0.93	0.71
Other Current Liabilities	-	-	-	1.09	2
Total Current Liabilities	205.8	126.55	87.06	64.73	42.6
Long-Term Debt	309.8	308.08	306.42	-	-
Long-Term Leases	7.52	7.97	0.62	1.26	1.9
Other Long-Term Liabilities	5.01	2.51	3.85	144.88	129.94
Total Long-Term Liabilities	322.32	318.56	310.89	146.14	131.84
Total Liabilities	528.12	445.11	397.95	210.87	174.44
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-in Capital	981.88	870.19	803.26	535.07	377.4
Accumulated Other Comprehensive Income	0.35	-0.37	1.64	-0.22	-0.04
Retained Earnings	-667.54	-644.18	-556.24	-392.82	-257.16
Shareholders' Equity	314.69	225.64	248.67	142.04	120.21
Total Liabilities & Equity	842.81	670.75	646.62	352.91	294.65
Total Debt	317.31	316.05	308.14	2.19	2.61
Net Cash (Debt)	66.01	-35.74	-21.82	149.53	153.93
Net Cash Growth	-	-	-	-2.86%	-32.65%
Net Cash Per Share	1.31	-0.75	-0.53	4.40	5.08
Book Value	314.69	225.64	248.67	142.04	120.21
Book Value Per Share	6.27	4.75	6.08	4.18	3.96
Tangible Book Value	53.77	-24.18	-4.26	140.66	101.47
Tangible Book Value Per Share	1.07	-0.51	-0.10	4.14	3.35

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q